Open AccessManagement of good-risk metastatic nonseminomatous germ cell tumors of the testis: Current concepts and controversies
Author(s) -
Gautam Jayram,
Russell Z. Szmulewitz,
Scott E. Eggener
Publication year - 2010
Publication title -
indian journal of urology/indian journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.333
H-Index - 30
eISSN - 1998-3824
pISSN - 0970-1591
DOI - 10.4103/0970-1591.60449
Subject(s) - medicine , germ cell tumors , retroperitoneal lymph node dissection , chemotherapy , lymph node , oncology , radiology , primary tumor , stage (stratigraphy) , teratoma , dissection (medical) , disease , localized disease , metastasis , surgery , cancer , testicular cancer , biology , prostate cancer , paleontology
Approximately 30% of nonseminomatous germ-cell tumors (NSGCT) of the testis present with metastatic disease. In 1997, the International Germ Cell Cancer Collaborative Group (IGCCCG) stratified all patients with metastatic NSGCT into various risk groups based on serum tumor markers and presence of visceral disease. We review the literature and present optimal stage-dependent management strategies in patients with favorable-risk metastatic NSGCT.